|
XB--988845
Papers associated with kcnip2 (and Disease Ontology)
???pagination.result.count???
???pagination.result.page??? 1
Sort Newest To Oldest | Sort Oldest To Newest |
Post-infection treatment with the E protein inhibitor BIT225 reduces disease severity and increases survival of K18-hACE2 transgenic mice infected with a lethal dose of SARS-CoV-2., Ewart G, Bobardt M, Bentzen BH, Yan Y, Thomson A, Klumpp K, Becker S, Rosenkilde MM, Miller M, Gallay P., PLoS Pathog. August 1, 2023; 19 (8): e1011328. ![]() |
|
KCND2 variants associated with global developmental delay differentially impair Kv4.2 channel gating., Zhang Y, Tachtsidis G, Schob C, Koko M, Hedrich UBS, Lerche H, Lemke JR, van Haeringen A, Ruivenkamp C, Prescott T, Tveten K, Gerstner T, Pruniski B, DiTroia S, VanNoy GE, Rehm HL, McLaughlin H, Bolz HJ, Zechner U, Bryant E, McDonough T, Kindler S, Bähring R., Hum Mol Genet. November 16, 2021; 30 (23): 2300-2314. |
???pagination.result.page??? 1